Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Pharmaceuticals and diagnostics technology producer Roche spun off Nimble Therapeutics, a US-based developer of chemical-synthesis drug discovery and development technology, on Tuesday with an amount of series A funding reported by Fierce Biotech to be $10m. Healthcare investment firm Telegraph Hill Partners led the round, which was closed as Nimble prepares to forge partnerships with…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.